NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球體外受精測試市場:行業分析、規模、份額、增長、趨勢和預測(2021-2031)

In Vitro Fertilization Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版商 Transparency Market Research 商品編碼 1018209
出版日期 內容資訊 英文 215 Pages
商品交期: 最快1-2個工作天內
價格
全球體外受精測試市場:行業分析、規模、份額、增長、趨勢和預測(2021-2031) In Vitro Fertilization Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
出版日期: 2021年05月31日內容資訊: 英文 215 Pages
簡介

本報告調查了全球試管嬰兒市場、市場規模和預測、趨勢和機遇、增長和製約因素、按測試類型/最終用戶/地區、競爭形勢、主要公司進行的市場分析。提供了概況等信息。

目錄

第一章前言

第 2 章先決條件和調查方法

第 3 章執行摘要:全球試管嬰兒市場

第 4 章市場概覽

  • 簡介
    • 市場介紹
    • 行業進步/發展
  • 概述
  • 市場動態
    • 增長因素
    • 抑製器
    • 市場機會
  • 全球體外受精測試市場分析與預測(2017-2031)
    • 市場盈利預測

第 5 章重要見解

  • 重大併購
  • COVID-19 大流行對行業的影響(價值鍊和短期/中期/長期影響)
  • 區域/全球監管情景
  • 市場經營的三大公司
  • 主要產品/品牌分析

第 6 章按測試類型分類:全球體外受精測試市場分析與預測

  • 介紹和定義
  • 主要發現/發展
  • 市場銷售預測:按檢驗類型(2017-2031)
    • 精子非整倍體檢測
    • 基因兼容性測試
    • 植入前基因檢測
    • 子宮內膜容受性分析
    • 無創產前檢測
    • 其他
  • 按檢驗類型劃分的市場吸引力分析

最終用戶第 7 章:全球試管嬰兒市場的分析和預測

  • 介紹和定義
  • 主要發現/發展
  • 市場銷售預測:按最終用戶(2017-2031)
    • 不孕不育診所
    • 醫院
    • 其他
  • 最終用戶的市場吸引力分析

第 8 章區域:全球體外受精市場分析和預測

  • 主要調查結果
  • 市場銷售預測:按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 按國家/地區分列的市場吸引力分析

第9章北美:體外受精測試市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場銷售預測:按檢驗類型(2017-2031)
  • 市場銷售預測:按最終用戶(2017-2031)
  • 市場銷售預測:按國家(2017-2031)
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按檢驗類型
    • 最終用戶
    • 按國家/地區

第 10 章歐洲:體外受精市場分析與預測

第 11 章亞太地區:體外受精市場分析與預測

第 12 章拉丁美洲:體外受精市場分析與預測

第 13 章中東和非洲:體外受精市場分析與預測

第14章競爭形勢

  • 市場企業-競爭矩陣(按企業層次結構和規模)
  • 市場份額分析:按公司(2020 年)
  • 公司簡介
    • CooperSurgical, Inc.
    • Esco Micro Pte Ltd.
    • FUJIFILM Irvine Scientific
    • Hamilton Thorne, Inc.
    • Vitrolife AB
    • IVFtech ApS
    • Nidacon International AB
    • Igenomix
    • Thermo Fisher Scientific
    • Cook
    • Genea Biomedx
    • FertiPro NV
    • Kitazato Corporation
    • PerkinElmer, Inc.
    • Natera
    • Takara Bio, Inc.
    • iGLS
    • CiceroDx
目錄
Product Code: TMRGL82310

Scope of the Report

TMR's report on the in vitro fertilization test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market over the forecast period from 2021 to 2031. The report provides the overall revenue of the global in vitro fertilization test market for the period of 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global in vitro fertilization test market for the forecast period of 2021-2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global in vitro fertilization test market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global in vitro fertilization test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the in vitro fertilization test market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the in vitro fertilization test market.

The report also delves into the competitive landscape of the global in vitro fertilization test market. Key players operating in the global in vitro fertilization test market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the in vitro fertilization test market profiled in this report.

Key Questions Answered:

  • How does the development of in vitro fertilization tests provide scope of growth in the global in vitro fertilization test market?
  • How alliances and partnerships among players are widening the scope of new line of technologies for in vitro fertilization test?
  • What are the revenue share projections of key segments under various criteria in the in vitro fertilization test market during the forecast period?
  • Which segment is likely to register highest revenue until the end of the forecast period in 2031?
  • How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall in vitro fertilization test market?

Research Objectives and Research Approach

The comprehensive report on the global in vitro fertilization test market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for in vitro fertilization test.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vitro fertilization test market in terms of test type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro fertilization test market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In Vitro Fertilization Test Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Introduction
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In Vitro Fertilization Test Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. COVID-19 Pandemics Impact on Industry (Value Chain and Short / Mid /Long Term Impact)
  • 5.3. Regulatory Scenario by Region/globally
  • 5.4. Top 3 players operating in the market space
  • 5.5. Key product/brand Analysis

6. Global In Vitro Fertilization Test Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Test Type, 2017-2031
    • 6.3.1. Sperm Aneuploidy Test
    • 6.3.2. Genetic Compatibility Test
    • 6.3.3. Preimplantation Genetic Testing
    • 6.3.4. Endometrial Receptivity Analysis
    • 6.3.5. Noninvasive Prenatal Testing
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Test Type

7. Global In Vitro Fertilization Test Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Fertility Clinics
    • 7.3.2. Hospitals
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global In Vitro Fertilization Test Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Country/Region

9. North America In Vitro Fertilization Test Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Test Type, 2017-2031
    • 9.2.1. Sperm Aneuploidy Test
    • 9.2.2. Genetic Compatibility Test
    • 9.2.3. Preimplantation Genetic Testing
    • 9.2.4. Endometrial Receptivity Analysis
    • 9.2.5. Noninvasive Prenatal Testing
    • 9.2.6. Others
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Fertility Clinics
    • 9.3.2. Hospitals
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Test Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe In Vitro Fertilization Test Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Test Type, 2017-2031
    • 10.2.1. Sperm Aneuploidy Test
    • 10.2.2. Genetic Compatibility Test
    • 10.2.3. Preimplantation Genetic Testing
    • 10.2.4. Endometrial Receptivity Analysis
    • 10.2.5. Noninvasive Prenatal Testing
    • 10.2.6. Others
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Fertility Clinics
    • 10.3.2. Hospitals
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Test Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific In Vitro Fertilization Test Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Test Type, 2017-2031
    • 11.2.1. Sperm Aneuploidy Test
    • 11.2.2. Genetic Compatibility Test
    • 11.2.3. Preimplantation Genetic Testing
    • 11.2.4. Endometrial Receptivity Analysis
    • 11.2.5. Noninvasive Prenatal Testing
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Fertility Clinics
    • 11.3.2. Hospitals
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Test Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America In Vitro Fertilization Test Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017-2031
    • 12.2.1. Sperm Aneuploidy Test
    • 12.2.2. Genetic Compatibility Test
    • 12.2.3. Preimplantation Genetic Testing
    • 12.2.4. Endometrial Receptivity Analysis
    • 12.2.5. Noninvasive Prenatal Testing
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Fertility Clinics
    • 12.3.2. Hospitals
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Test Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa In Vitro Fertilization Test Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017-2031
    • 13.2.1. Sperm Aneuploidy Test
    • 13.2.2. Genetic Compatibility Test
    • 13.2.3. Preimplantation Genetic Testing
    • 13.2.4. Endometrial Receptivity Analysis
    • 13.2.5. Noninvasive Prenatal Testing
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Fertility Clinics
    • 13.3.2. Hospitals
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Test Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 14.2. Market Share Analysis, by Company, 2020
  • 14.3. Company Profiles
    • 14.3.1. CooperSurgical, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Growth Strategies
      • 14.3.1.3. SWOT Analysis
    • 14.3.2. Esco Micro Pte Ltd.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Growth Strategies
      • 14.3.2.3. SWOT Analysis
    • 14.3.3. FUJIFILM Irvine Scientific
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Growth Strategies
      • 14.3.3.3. SWOT Analysis
    • 14.3.4. Hamilton Thorne, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Growth Strategies
      • 14.3.4.3. SWOT Analysis
    • 14.3.5. Vitrolife AB
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Growth Strategies
      • 14.3.5.3. SWOT Analysis
    • 14.3.6. IVFtech ApS
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Growth Strategies
      • 14.3.6.3. SWOT Analysis
    • 14.3.7. Nidacon International AB
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Growth Strategies
      • 14.3.7.3. SWOT Analysis
    • 14.3.8. Igenomix
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Growth Strategies
      • 14.3.8.3. SWOT Analysis
    • 14.3.9. Thermo Fisher Scientific
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Growth Strategies
      • 14.3.9.3. SWOT Analysis
    • 14.3.10. Cook
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Growth Strategies
      • 14.3.10.3. SWOT Analysis
    • 14.3.11. Genea Biomedx
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Growth Strategies
      • 14.3.11.3. SWOT Analysis
    • 14.3.12. FertiPro N.V
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Growth Strategies
      • 14.3.12.3. SWOT Analysis
    • 14.3.13. Kitazato Corporation
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Growth Strategies
      • 14.3.13.3. SWOT Analysis
    • 14.3.14. PerkinElmer, Inc.
      • 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.14.2. Growth Strategies
      • 14.3.14.3. SWOT Analysis
    • 14.3.15. Natera
      • 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.15.2. Growth Strategies
      • 14.3.15.3. SWOT Analysis
    • 14.3.16. Takara Bio, Inc.
      • 14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.16.2. Growth Strategies
      • 14.3.16.3. SWOT Analysis
    • 14.3.17. iGLS
      • 14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.17.2. Growth Strategies
      • 14.3.17.3. SWOT Analysis
    • 14.3.18. CiceroDx
      • 14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.18.2. Growth Strategies
      • 14.3.18.3. SWOT Analysis

List of Tables

  • Table 01: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 06: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 09: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 12: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
  • Table 14: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 15: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 18: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global In-vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global In-vitro Fertilization Test Market Value Share, by Test Type, 2020
  • Figure 03: Global In-vitro Fertilization Test Market Value Share, by End-user, 2020
  • Figure 04: Global In-vitro Fertilization Test Market Value Share, by Region, 2020
  • Figure 05: Global In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 06: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 07: Global In Vitro Fertilization Test Market Value (US$ Mn), by Sperm Aneuploidy Test, 2017-2031
  • Figure 08: Global In Vitro Fertilization Test Market Value (US$ Mn), by Genetic Compatibility Test, 2017-2031
  • Figure 09: Global In Vitro Fertilization Test Market Value (US$ Mn), by Preimplantation Genetic Testing, 2017-2031
  • Figure 10: Global In Vitro Fertilization Test Market Value (US$ Mn), by Endometrial Receptivity Analysis, 2017-2031
  • Figure 11: Global In Vitro Fertilization Test Market Value (US$ Mn), by Noninvasive Prenatal Testing, 2017-2031
  • Figure 12: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
  • Figure 13: Global In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 14: Global In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 15: Global In Vitro Fertilization Test Market Value (US$ Mn), by Fertility Clinics, 2017-2031
  • Figure 16: Global In Vitro Fertilization Test Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 17: Global In Vitro Fertilization Test Market Value (US$ Mn), by Others, 2017-2031
  • Figure 18: Global In Vitro Fertilization Test Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 19: Global In Vitro Fertilization Test Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 20: North America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: North America In Vitro Fertilization Test Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 22: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 23: North America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 24: North America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 25: North America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 26: North America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 27: Europe In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 28: Europe In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 29: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 30: Europe In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 31: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 32: Europe In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 33: Europe In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 34: Asia Pacific In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 36: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 37: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 38: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 39: Asia Pacific In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 40: Asia Pacific In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 41: Latin America In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 43: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 44: Latin America In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 45: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 46: Latin America In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 47: Latin America In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 48: Middle East & Africa In Vitro Fertilization Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 49: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 50: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 51: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by Test Type, 2020 and 2031
  • Figure 52: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by Test Type, 2021-2031
  • Figure 53: Middle East & Africa In Vitro Fertilization Test Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 54: Middle East & Africa In Vitro Fertilization Test Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 55: Global In Vitro Fertilization Test Market: Company Share Analysis, 2020
  • Figure 56: CooperSurgical, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 57: CooperSurgical, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 58: CooperSurgical, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

Figure 59: CooperSurgical, Inc. R&D Expenses (US$ Mn) Y-o-Y Growth (%), 2017-2020

  • Figure 60: FUJIFILM Holding Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
  • Figure 61: FUJIFILM Holding Corporation Revenue Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 62: FUJIFILM Holding Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 63: Hamilton Thorne, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
  • Figure 64: Hamilton Thorne, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 65: Hamilton Thorne, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
  • Figure 66: Vitrolife AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 67: Vitrolife AB Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 68: Vitrolife AB Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 69: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 70: Thermo Fisher Scientific Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 71: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 72: Thermo Fisher Scientific R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 73: PerkinElmer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 74: PerkinElmer, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 75: PerkinElmer, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 76: PerkinElmer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
  • Figure 77: Natera Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 78: Natera Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 79: Natera R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020
  • Figure 80: Takara Bio, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 81: Takara Bio, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 82: Takara Bio, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 83: Takara Bio, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018-2020